This inventor holds 23 USPTO granted patents, primarily in Monoclonal Antibodies. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Mitsubishi Oil Co., Ltd., Kyowa Hakko Bio Co., Ltd.. Active years: 1978-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sagamihara, JA (1978)
- Sagamihara, JP (1990 - 1995)
- Kanagawa, JP (1987 - 2000)
Company Filing History:
15 out of 730 
5 out of 54 
2 out of 104 
Years Active: 1978-2000
Areas of Expertise:
Title: Hajime Yoshida: Innovator in Granulocyte Colony Stimulating Factor Research
Introduction
Hajime Yoshida is a prominent inventor based in Kanagawa, Japan, known for his significant contributions to the field of biotechnology, particularly in the development of human granulocyte colony stimulating factor (hG-CSF) polypeptide derivatives. With a remarkable portfolio of 23 patents, his work has been instrumental in advancing therapeutic solutions for various medical conditions.
Latest Patents
Yoshida's latest innovations include patents focused on novel hG-CSF polypeptide derivatives. These derivatives are characterized by amino acid sequences that have been modified through the substitution or deletion of specific amino acids. His patents also describe recombinant plasmids that contain DNA fragments coding for these hG-CSF polypeptide derivatives, along with the methods for producing these peptides using microorganisms. In addition, his work encompasses monoclonal antibodies that bind to the hG-CSF polypeptide derivatives and discusses chemically modified hG-CSF or its derivatives, showcasing his extensive research and innovation in the field.
Career Highlights
Throughout his career, Hajime Yoshida has been associated with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Mitsubishi Oil Co., Ltd. His expertise and groundbreaking work in biomedicine have positioned him as a respected figure in his field, with a focus on developing therapeutic proteins and enhancing their efficacy.
Collaborations
Yoshida's innovative journey has been enriched by collaborations with esteemed colleagues, including Tetsuro Kuga and Hiromasa Miyaji. Together, they have contributed to multiple advancements in biotechnology and engineering, paving the way for future research and development in therapeutic applications.
Conclusion
Hajime Yoshida's work exemplifies the spirit of innovation in the biotech industry. With a solid foundation built on his numerous patents and collaborations, he continues to influence the development of cutting-edge therapies that have the potential to improve patient outcomes and advance medical science. His contributions serve as an inspiration for future inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile